Correction to: Efficacy of canakinumab as first-line biologic agent in adult-onset Still’s disease

Detalles Bibliográficos
Autores principales: Cavalli, Giulio, Tomelleri, Alessandro, De Luca, Giacomo, Campochiaro, Corrado, Dinarello, Charles A., Baldissera, Elena, Dagna, Lorenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6388469/
https://www.ncbi.nlm.nih.gov/pubmed/30803447
http://dx.doi.org/10.1186/s13075-019-1850-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6388469/
https://www.ncbi.nlm.nih.gov/pubmed/30803447
http://dx.doi.org/10.1186/s13075-019-1850-x

Ejemplares similares